Alcista
$1.78
Precio del escenario
$2.730
+0.072 (+2.63%)Al cierre
3D Systems Corporation provides comprehensive three-dimensional (3D) printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The Company’s segments include Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment serves industry verticals, including dental, medical devices, personalized health services and regenerative medicine. The Industrial Solutions segment serves industry verticals, including aerospace, defense, transportation and general manufacturing. The Company architects solutions specific to customers’ needs through a combination of materials, hardware platforms, software, professional services and advanced manufacturing. It markets its products and services through subsidiaries in North America and South America, Europe and the Middle East and Asia Pacific and Oceania.
3D Systems Corp is currently a hold. The stock is trading at $2.66, significantly below its 52-week high of $4.12, indicating potential upside. However, the RSI is at a low 20.36, suggesting oversold conditions, but also a lack of bullish momentum. The forward P/E ratio is 22.52, which is high given the recent earnings history and negative net income. The company has shown some positive developments, such as a 6.8% increase in Healthcare Solutions revenue, but it also faces risks, including a significant 25.28% decline over the past 20 days and ongoing losses, with a net income of -12.86 million in Q2 2026. Therefore, while there are growth opportunities, the current volatility and lack of consistent profitability suggest holding rather than buying at this time.
Craig-Hallum
$6
2026-08-04
Craig-Hallum
2026-08-04
Precio objetivo
$6
Needham
—
2025-03-28
Needham
2025-03-28
Precio objetivo
—
Cantor Fitzgerald
$5
2025-03-28
Cantor Fitzgerald
2025-03-28
Precio objetivo
$5
Needham
—
2025-01-15
Needham
2025-01-15
Precio objetivo
—
Needham
—
2024-12-12
Needham
2024-12-12
Precio objetivo
—
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

3D Systems Expands Partnership with BioSummer Dental for Digital Dentistry

3D Systems Donates 3D Printer to Enhance Healthcare Access

Precision Resource Expands U.S. Additive Manufacturing Network

New Colorado Facility Enhances 3D Printing Capabilities

3D Systems Opens New Industrial Technology Center in Colorado to Boost Domestic Manufacturing
3D Systems Corporation provides comprehensive three-dimensional (3D) printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The Company’s segments include Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment serves industry verticals, including dental, medical devices, personalized health services and regenerative medicine. The Industrial Solutions segment serves industry verticals, including aerospace, defense, transportation and general manufacturing. The Company architects solutions specific to customers’ needs through a combination of materials, hardware platforms, software, professional services and advanced manufacturing. It markets its products and services through subsidiaries in North America and South America, Europe and the Middle East and Asia Pacific and Oceania. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).
3D Systems Corp is currently a hold. The stock is trading at $2.66, significantly below its 52-week high of $4.12, indicating potential upside. However, the RSI is at a low 20.36, suggesting oversold conditions, but also a lack of bullish momentum. The forward P/E ratio is 22.52, which is high given the recent earnings history and negative net income. The company has shown some positive developments, such as a 6.8% increase in Healthcare Solutions revenue, but it also faces risks, including a significant 25.28% decline over the past 20 days and ongoing losses, with a net income of -12.86 million in Q2 2026. Therefore, while there are growth opportunities, the current volatility and lack of consistent profitability suggest holding rather than buying at this time.
16 analysts cover DDD: 1 rate it Buy, 10 Hold and 5 Sell. The average price target is 5.00.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.